25.86
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com
Amphastar Pharmaceuticals Stockholders Approve Key Amendments - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in May - Defense World
Squarepoint Ops LLC Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Significant Growth in Short Interest - MarketBeat
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Nuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar price target lowered to $35 from $40 at Wells Fargo - MSN
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Man Group plc Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Voloridge Investment Management LLC - MarketBeat
Deutsche Bank AG Buys 10,839 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 792 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Deutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Twinbeech Capital LP Invests $1.74 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Ameriprise Financial Inc. Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by BNP Paribas Financial Markets - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Janus Henderson Group PLC - MarketBeat
246,348 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by Systematic Financial Management LP - MarketBeat
D. E. Shaw & Co. Inc. Boosts Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers - FinancialContent
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - ACCESS Newswire
Amphastar CFO to Lead Fireside Chat at Jefferies Global Healthcare Conference June 5 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Northern Trust Corp Acquires 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Jane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals' (AMPH) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
Comerica Bank Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given “Neutral” Rating at JPMorgan Chase & Co. - Defense World
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals, Comstock, Range Resources - TradingView
Amphastar Pharmaceuticals: Navigating Through An Inflection Year (NASDAQ:AMPH) - Seeking Alpha
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Wells Fargo & Company Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $35.00 - Defense World
大文字化:
|
ボリューム (24 時間):